Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

X4 Pharmaceuticals (XFOR) Assets Average (2018 - 2025)

Historic Assets Average for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q3 2025 value amounting to $134.4 million.

  • X4 Pharmaceuticals' Assets Average fell 3087.97% to $134.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $134.4 million, marking a year-over-year decrease of 3087.97%. This contributed to the annual value of $146.9 million for FY2024, which is 301.77% down from last year.
  • According to the latest figures from Q3 2025, X4 Pharmaceuticals' Assets Average is $134.4 million, which was down 3087.97% from $117.6 million recorded in Q2 2025.
  • In the past 5 years, X4 Pharmaceuticals' Assets Average registered a high of $194.4 million during Q3 2024, and its lowest value of $90.3 million during Q2 2022.
  • In the last 5 years, X4 Pharmaceuticals' Assets Average had a median value of $138.2 million in 2025 and averaged $138.6 million.
  • Per our database at Business Quant, X4 Pharmaceuticals' Assets Average plummeted by 4032.12% in 2022 and then skyrocketed by 7831.66% in 2023.
  • Quarter analysis of 5 years shows X4 Pharmaceuticals' Assets Average stood at $118.8 million in 2021, then grew by 13.17% to $134.5 million in 2022, then increased by 19.17% to $160.3 million in 2023, then increased by 1.27% to $162.3 million in 2024, then decreased by 17.22% to $134.4 million in 2025.
  • Its last three reported values are $134.4 million in Q3 2025, $117.6 million for Q2 2025, and $138.2 million during Q1 2025.